Arcturus Therapeutics (ARCT) PT Raised to $138 at B.Riley/FBR, Following Clinical Update
Tweet Send to a Friend
B.Riley/FBR analyst Chad L. Mabry ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
